Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation

Liver Transplantation and Surgery

Volumn 2, Issue 4, 1996, Pages 263-268

  Safadi, R ^a   Shouval, D ^a   Kaspa, R T ^a   Ashur, Y ^a   Ilan, Y ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG EFFECT; HEPATITIS C; HUMAN; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; REINFECTION; VIRUS DETECTION; VIRUS REPLICATION;

EID: 0029680128     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500020403     Document Type: Article

References (44)

1. 1 Smedile A, Marzano A, Farci P, Chiaberg E, Abate M, Ottobrelli A, et al. Liver transplant for viral hepatitis. Recurrence of reinfection. J Hepatol 1991 ; 13 (suppl) 4: S134–S137.
2. 2 Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus (HBV) related liver disease. Hepatology 1991 ; 4: 619–626.
3. 3 Ottobrelli A, Marzano A, Smedile A, Ferrell L, Galbraith C, Kuramoto IK, et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991 ; 101: 1649–1655.
4. 4 Read AE, Donegan E, Lake J, et al. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med 1991 ; 114: 282–284.
5. 5 Martin P, Munoz S, Di Besceglie A, Rubin R, Waggoner J, Armenti V, et al. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology 1991 ; 13: 719–721.
6. 6 Marzano A, Smedile A, Abate M, Ottobrelli A, Brunetto M, Negro F, et al. Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence. J Hepatol 1994 ; 21: 961–965.
7. 7 Popp JW Jr, Dienstag JL, Wands JR, Bloch KJ. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med 1980 ; 92: 379–383.
8. 8 Levo Y, Gorevic PD, Kassab HJ, Zucker‐Franklin D, Franklin EC. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977 ; 296: 1501–1504.
9. 9 Ilan Y, Hillman M, Oren R, Zlotogorski A, Shouval D. Vasculitis and cryoglobulinemia associated with persisting cholestatic hepatitis A virus infection. Am J Gastroenterol 1990 ; 85: 586–587.
10. 10 Gumber SC, Chopra S. ! Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995 ; 123: 615–620.
11. 11 Rahamimov R, Ilan Y, Eid A, Shouval D, Tur Kaspa R. Hepatitis C associated cryoglobulinemia after liver transplantation. Transplantation 1995 ; 60: 1050–1051.
12. 12 Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974 ; 57: 775–788.
13. 13 Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, et al. Detection of hepatitis C viral sequences in blood donations by „nested”︁ polymerase chain reaction and prediction of infectivity. Lancet 1990 ; 335: 1419–1422.
14. 14 Meltzer M, Franklin EC. Cryoglobulinemia: a study of twenty‐nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 1966 ; 40: 828–836.
15. 15 Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia: a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966 ; 40: 837–856.
16. 16 Invernizzi F, Galli M, Serino G, Monti G, Meroni PL, Granatieri C, et al. Secondary and essential cruoglobulinemias: frequency, nosological classification, and longterm follow‐up. Acta Haematol 1983 ; 70: 73–82.
17. 17 Bombardieri S, Paoletti P, Ferri C, Di Munno O, Fornai E, Giuntini C. Lung involvement in essential mixed cryoglobulinemia. Am J Med 1979 ; 66: 748–756.
18. 18 Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long‐term follow‐up of 40 patients. Am J Med 1980 ; 69: 287–308.
19. 19 Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993 ; 328: 465–470.
20. 20 Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II mixed cryoglobulinemia. N Engl J Med 1992 ; 327: 1490–1495.
21. 21 Durand JM, Lefevre P, Harle JR, Boucrat J, Vitvitski L, Soubeyrand J. Cutaneous vasculitis and cryoglobulinemia type II associated with hepatitis C virus infection [letter]. Lancet 1991 ; 337: 499–500.
22. 22 Ferri C, Longombardo G, Marzo E, Pasero G, Bombardieri S, Greco F, et al. Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection 1991 ; 19: 417–420.
23. 23 Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991 ; 34: 1606–1610.
24. 24 Pawlotsky J‐M, Ben Yahia M, Andre C, Voisin M‐C, Intrator L, Roudot‐Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: A prospective case‐control study. Hepatology 1994 ; 19: 841–848.
25. 25 Arribas JR, Barbado FJ, Zapico R, Sendino A, Gonzalez I, Vazquez JJ. Association between hepatitis C virus and mixed cryoglobulinemia. Rev Infect Dis 1991 ; 13: 770–771.
26. 26 Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992 ; 117: 573–577.
27. 27 Lunel F, Musset L, Cacoub P, Freangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994 ; 106: 1291–1300.
28. 28 Abuaf N, Lunel F, Giral P, Borotto E, Laperche S, Poupon R, et al. Non‐organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993 ; 18: 359–364.
29. 29 Pechere‐Bertschi A, Perrin L, de Saussure P, Widmann JJ, Giostra E, Schifferli JA. ! Hepatitis C: a possible etiology for cryoglobulinemia type II. Clin Exp Immunol 1992 ; 89: 419–422.
30. 30 Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991 ; 88: 2451–2455.
31. 31 Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993 ; 74: 1093–1102.
32. 32 Yoshioko K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferonalpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992 ; 16: 293–299.
33. 33 Nousbaum JB, Pol S, Gigou M, Okamoto H, Feray C, Poussin K, et al. HCV genotype II is associated to liver cirrhosis, cancer and low response to interferon alpha in European patients. Hepatology 1993 ; 18: 88A.
34. 34 Valbonesi M, Montani L, Florio G, Vecchi C. Plasmapheresis and cytotoxic drugs for mixed cryoglobulinemia. Haematologia (Budap) 1984 ; 17 (3): 341–351.
35. 35 Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 1987 ; 83: 726–730.
36. 36 Ferri C, Marzo E, Longombardo G, Lombardini F, Greco F, Bombardieri S. Alpha interferon in the treatment of mixed cryoglobulinemia patients. Eur J Cancer. 1991 ; 27 (suppl 4): S81–S82.
37. 37 Casato M, Legana B, Antonelli G, Dianzani F, Bonomo L. Long‐term results of therapy with interferon‐α for type II essential mixed cryoglobulinemia. Blood 1991 ; 78: 3142–3147.
38. 38 Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi P, et al. Interferon alfa 2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994 ; 330: 751–756.
39. 39 Feray C, Samuel D, Thiers V, Gigon M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992 ; 89: 1361–1365.
40. 40 Ferrell LD, Wright TL, Roberts J, Asher N, Lake J. Pathology of hepatitis C viral infection in liver transplant recipients. Hepatology 1992 ; 16: 865–876.
41. 41 Wright TL, Donegan E, Hsu HH, Ferrell L, Lake J, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992 ; 103: 317–322.
42. 42 Misiani R, Bellavita P, Fenili D. Interferon α‐2a therapy in cryoglobulinemia associated with HCV. N Engl J Med 1994 ; 330: 751–756.
43. 43 Reichard O, Andersson J, Schvarcz R, Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet 1991 ; 337: 1058–1061.
44. 44 Khella SL, Frost S, Hermann GA, Leventhal L, Whyatt S, Sajid MA, Scherer SS. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review. Neurology 1995 ; 45: 407–411.